| Health Care Services |
When |
| Physical exam |
Ages 7 to 10: one visit every 12-24 months
Ages 11 to 12: one visit annually
|
| Clinical Screenings |
When |
Blood pressure, height and weight, physical assessment and BMI percentile
|
During physical exam. BMI percentile: Include counseling for nutrition and
physical activity.
|
| Hearing screening |
Every two years |
| Dyslipidemia screening (risk assessment based on family history and physical exam) |
Assessment at ages 8 and 10, then annually. (Routine lab testing not recommended. May be done for children at high risk.)
|
| Urinalysis |
Once between ages 11 and 21 |
| Vision screening |
Once between ages 7 and 12 |
| Hemoglobin and hematocrit |
Once between ages 11 and 21 |
| Tuberculin skin test (PPD) |
For those identified as high risk |
| Prevention of dental cavities |
Prescribe oral fluoride supplementation if primary water source is deficient |
| Tobacco use |
All adolescents |
Depression screening
|
During physical exam ages 12 and older
|
| Alcohol/drug misuse |
All adolescents |
| Immunizations |
When |
MMR
Measles, mumps and rubella
|
Two doses if not vaccinated previously or no history of disease. |
HepB
Hepatitis B |
May begin three-dose series if not vaccinated in infancy. |
Tdap
Tetanus, diphtheria and acellular pertussis |
Ages 11-12: A single dose of Tdap instead of Td for booster immunization.
(Subsequent Td every ten years) |
Var
Varicella (chickenpox) |
Two-dose series at least four weeks apart (if no history of varicella and no previous vaccination). |
Flu
Influenza |
Annually. For children aged < 9 years, give two doses if receiving influenza for the first time (four-week interval). |
Pneumonia
Pneumococcal |
For high risk groups |
HepA
Hepatitis A |
At physician discretion: Two doses for all children and adolescents up to
six months apart if not vaccinated previously and high risk. |
| Meningococcal |
Between 11-12 years. |
HPV
Human Papillomavirus |
Three-dose series at age 11-12 years on a zero, two and six-month
schedule. Minimum spacing: Four weeks between #1 and #2; 12 weeks
between #2 and #3; must be 24 weeks between doses #1 and #3. |
